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Abstract 
Objectives: Irritable bowel syndrome (IBS) is common and adversely affects patients’ quality 
of life.  Multiple potential treatment options exist for patients (and clinicians) to choose from, 
with limited evidence to inform treatment selection.  The aim was to explore how patients 
with IBS go about seeking and appraising different treatment modalities, with a view to 
elucidating the psychological processes involved and identifying opportunities to improve 
clinical practice.   
Design: Qualitative study nested within a randomised controlled trial of therapist-delivered 
and web-based cognitive behavioural therapy versus treatment-as-usual for IBS. 
Methods: 52 people participated in semi-structured interviews about their prior experiences of 
treatments for IBS. Transcripts were analysed using inductive thematic analysis.  
Results: Key themes (desperation for a cure, disappointment at lack of cure, appraising the 
effects of diverse treatments, and hope for positive effects) clustered around an overarching 
theme of being trapped within a vicious cycle of hope and despair on treatment seeking.  A 
desperation and willingness drove interviewees to try any treatment modality available that 
might potentially offer relief.  Coming to accept there is no cure for IBS helped interviewees 
escape the vicious cycle.  Treatments were appraised for their effects on symptoms and 
quality of life while also considering, but rarely prioritising, other aspects including: 
convenience of the regimen itself, whether it addressed the perceived root causes of IBS, 
perceived side-effects, and cost.   
Conclusion: Treatment seeking in IBS can be challenging for patients.  Supportive 
discussions with health care professionals about illness perceptions, treatment beliefs, and 
goals could improve patients’ experiences.   
 
Trial Registration number: ISRCTN44427879 
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Introduction 
Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder or 
disorder of gut-brain interaction, currently conceptualised as involving multiple interacting 
biopsychosocial factors (Drossman, 2016).  It affects around 10-14.9% of the UK population 
with similar worldwide prevalence (Michalsen, Vandvik, & Farup, 2015; for a review see 
Lovell & Ford, 2012), and it affects more women than men (Quigley, Bytzer, Jones, & 
Mearin, 2006).  Symptoms include abdominal pain, discomfort and altered bowel 
movements, and personal, social, professional, and health-related quality of life is typically 
reduced (El-Serag, Olden, & Bjorkman, 2013; Håkanson, Sahlberg-Blom, Nyhlin, & 
Ternestedt, 2009; Taft et al. 2011; 2013; 2014).   
Few current treatments offer satisfactory symptom relief (Schoenfeld, 2005).  NICE 
clinical guidelines (2008, updated 2017) recommend clinicians provide advice on the 
importance of self-help for the effective management of IBS, where self-help encompasses 
lifestyle adjustments, general diet advice, advice to be physically active, and symptom-
focused medications.  If general dietary advice is ineffective then NICE recommend single 
food avoidance and exclusion diets under the supervision of a healthcare professional with 
expertise in dietary management.  Beyond self-care, NICE recommend considering 
pharmacological management based on symptom type and severity, and the use of 
psychological therapies where symptoms have persisted for more than 12-months.   
Trials, systematic reviews, and meta-analyses, suggest that some treatment modalities 
are helpful in reducing IBS symptom severity.  However, many trials lack methodological 
rigour, thus the findings should be treated with caution.  For instance, a limited number of 
studies have tested the effectiveness of the low Fermentable Oligo-, Di-, Mono-saccharides 
and Polypols (FODMAP) diet.  While these studies report a reduction in symptom severity, 
the effects are similar to other interventions e.g. less-restrictive dietary advice (see Eswaran, 
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Chey, Han-Markey, Ball, & Jackson, 2016; Marsh, Eslick, & Eslick, 2016).  In relation to 
pharmacological interventions, a Cochrane review offered some support for antidepressants, 
but little support for bulking agents and antispasmodics (Ruepert et al., 2011).  In relation to 
psychological interventions, systematic reviews and meta-analyses have shown CBT to be 
efficacious in the short-term, with equivocal findings so far for longer-term outcomes (Li, 
Xiong, Zhang, Yu, & Chen, 2014; Zijdenbos, de Wit, van der Heijden, Rubin, & Quartero, 
2009). 
The NICE guidelines recommend clinicians not to encourage the use of acupuncture 
and reflexology, but between 20 and 50% of people with IBS use some form of 
complementary or alternative medicine (CAM) (Carmona-Sanchez & Tostado-Fernandez, 
2004; Hung, Kang, Bollom, Wolf, & Lembo, 2015; Koloski, Talley, Huskic, & Boyce, 2003; 
Kong et al., 2005).  Using CAM can be motivated by a lack of response to conventional 
treatments and the disabling nature of IBS symptomology (Hussain & Quigley, 2006; Wu, 
2010).  While recent evidence suggests some CAMs may be helpful (see for example 
Bensoussan et al., 2015; Cappello, Spezzaferro, Grossi, Manzoli, & Marzio, 2007; 
Manheimer et al., 2012) Wu’s (2010) review found the poor quality of trials in this area 
precluded judgments as to their effectiveness.   
Håkanson et al. (2009) and Jakobson Ung, Ringstrom, Sjövall, and Simrén (2013) 
have explored how individuals seek ways of coping with, and adjusting to, life with IBS.  In 
these qualitative studies, interviewees were described as having an altered self-image due to 
symptoms like bloating and flatulence (Håkanson et al., 2009), wanting more autonomy in 
treatment decisions (Håkanson et al., 2009), coming to accept they could not be cured 
(Jakobson Ung et al., 2013), and seeking coping strategies to regain a sense of control in their 
lives (Håkanson et al., 2009; Jakobson Ung et al., 2013).  They also described living a life 
revolving round ‘periods of well-being interspersed with periods of deterioration and illness’ 
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(Jakobson Ung et al., 2013; p.1482).  Relatedly, Paterson's (2001) meta-synthesis described 
how living with IBS involves diametrically opposite sequences, in which individuals mainly 
focused on managing symptoms during flare-ups but on strategies to protect themselves from 
further relapses in symptom-free times.   
The idea that symptom experiences shape coping strategies has been formalised in the 
Common Sense Model (Diefenbach & Leventhal, 1996; Leventhal, Meyer, & Nerez, 1980; 
Leventhal, Nerenz, & Steele, 1984).  According to this model, when people experience 
symptoms they develop cognitive and affective representations that drive coping strategies 
including treatment-seeking.  The experience and effects of treatment are then appraised, and 
inform modifications to illness representations, treatment utilisation, or both (Diefenbach & 
Leventhal, 1996; Horne, 2003; Horne & Weinman, 2002; Leventhal et al., 1980, 1984). The 
criteria by which patients appraise treatments may vary by treatment and/or condition (Dima 
et al., 2013); for example, the therapist might be particularly important in shaping appraisals 
of complementary therapies (Bishop, Yardley, Cooper, Little, & Lewith, 2017; Yardley, 
Sharples, Beech, & Lewith, 2001) while beliefs about necessity and concerns are important 
for medications (Horne et al., 2013).   
The Common Sense Model has been applied in IBS, but the focus thus far has been 
on the role of illness perceptions rather than treatment appraisals.  De Gucht (2015) found the 
impact of increased symptom severity on reduced health-related quality of life was partially 
mediated by the illness perception dimensions of identity, consequences, and emotional 
representation. Rutter and Rutter (2002) found higher rates of anxiety and depression were 
strongly associated with perceiving IBS as having severe consequences. Riedl et al. (2009) 
found that people who attributed their IBS to psychological factors had a better quality of life 
than those with somatic attributions.  While qualitative studies have explored patients’ 
experiences of IBS in general, no in-depth studies have explicitly focused on how patients 
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experience and appraise treatments.  It is important to explore how patients experience and 
appraise treatments for IBS because of the treatment context faced by patients: a variety of 
potential modalities which offer limited symptom relief that are not all widely available on 
the NHS.   
This paper reports the findings from a qualitative study nested within a three-armed 
randomised controlled trial of therapist- and web-based CBT vs treatment as usual for IBS 
(citation removed for peer review).  The aim was to explore how patients with refractory IBS 
seek and appraise different treatment modalities tried prior to entering the trial.  Patients’ 
experiences of CBT in the trial will be reported elsewhere.   
Method 
Design 
This qualitative study was nested within a large trial (summarised below) and used a 
critical realist theoretical framework (Bhaskar, 1975; Gerrits & Verweij, 2015).  Semi-
structured interviews were conducted with a subsample of participants drawn from each arm 
of the trial on completing trial treatments (3 months post-baseline).  Adopting an inductive 
and thematic approach permitted us to compare themes across individuals and groups of 
people (e.g. genders, IBS severity scores, primary and secondary care) as well as analysing 
key themes across the whole dataset.  
The Parent Trial 
The main trial randomised patients to receive therapist-delivered CBT, web-based 
CBT or treatment-as-usual (see Table 1 for summary, and (citation removed for peer review) 
for full description of interventions).  Eligible patients were diagnosed with refractory IBS 
fulfilling the Rome III criteria (Drossman, 2006) and were aged 18 years or over (for full 
details of trial methods see (citation removed for peer review)). 
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Participants 
Maximum variation sampling was employed to interview people with a diverse range 
of characteristics: age, gender, ethnicity, geographical location, study arm, symptom severity 
scores, and from primary and secondary care.  
Fifty-two interviews were conducted, 42 by XX and 10 by XX.  Interviewees were 
aged from 21 to 74 years (M = 40.67, SD = 14.05) and had IBS for an average of 16.26 years 
(SD = 9.96).  Table 2 summarises interviewees’ characteristics.   
Interviews 
Semi-structured interviews used a topic guide comprising broad, open-ended 
questions clustered into three sections: experiences of the trial to date, treatment regimens for 
IBS, and daily experiences of emotions (findings from the latter have been published 
separately; see (citation removed for peer review)).  This paper focuses on interviewee 
responses to questions exploring past treatment regimens for IBS.  Questions included “could 
you tell me about the most helpful/least helpful treatments you have tried for your IBS?” and 
“What did you like/dislike about these treatments?”  These questions did not explore the 
interviewees’ experiences of CBT or treatment-as-usual received during the trial.  Interviews 
lasted on average 56 minutes (range 23 to 116) and were conducted face-to-face (n = 10) or 
over the telephone (n = 42), as per participant request. 
Procedure 
Prior to commencing the study, favourable NHS ethical clearance was received (ref: 
Berkshire REC 13/SC/0206).  At the start of the trial, informed consent for interview 
participation was obtained.  Before commencing each interview, interviewers built rapport, 
reminded interviewees of their rights, and obtained verbal consent.  Interviews were digitally 
recorded, then transcribed and coded using NVivo (version 10; QSR International Ltd., 
2012).  Interviewers made field notes (e.g. observations of non-verbal aspects) to inform later 
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analysis and document their own reflections.  All participant names have been anonymised to 
protect confidentiality. 
Data Analysis 
Thematic analysis was used to identify themes (Joffe & Yardley, 2004), and followed 
the procedure espoused by Braun and Clarke (2013).  To achieve familiarisation with the 
data, interviews were listened to and transcripts read repeatedly.  Memos were written to 
capture the researcher’s subjective thoughts and feelings, and preserve ideas that may become 
significant later in the analysis (Polit & Beck, 2004; Speziale & Carpenter, 2007).  To 
generate initial themes based on the data, XX read each transcript and attached newly devised 
labels to phrases and small chunks of data that addressed the research question.  After 
conducting open-coding in this way on five transcripts, all labels and associated data excerpts 
were collated and reviewed.  This process identified a large number of codes which were 
used to code the remaining transcripts, adding more codes when new ideas were encountered 
in the data.  
Codes were defined in a coding manual and clustered around common themes; 
clusters were identified by comparing different codes and associated data excerpts.  
Preliminary themes were defined, diagrammed (in thematic maps), and reviewed against 
transcripts to ensure coherence and consistency with the dataset overall.  Other researchers 
were involved at this stage (XX, XX) to discuss the themes and suggest alternative 
interpretations of the data, thus ensuring the analysis was neither idiosyncratic nor 
inappropriately selective.  Themes were modified and discussed iteratively and finalised 
when the team agreed they captured the interviewees’ experiences of previous IBS 
treatments. 
We ran queries in NVivo to explore similarities and differences between groups of 
interviewees (Bazeley & Jackson, 2014).  For example, a “matrix query” explored how 
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interviewees in the different trial arms experienced pharmacological treatments.  Overall, 
these queries suggested that experiencing and appraising treatments was similar across 
interviewees with different characteristics and from the different trial arms.  Therefore, these 
queries are reported no further.   
Study Rigour 
To enhance the quality and rigour of this study we followed Lincoln & Guba's 
guidelines (1985).  Trustworthiness was enhanced through keeping a clear audit trail and 
having regular discussions of emerging themes and findings within the research team.  
Maximum variation sampling helps to increase confidence that we have captured major 
themes of importance to a diverse sample of people seeking help for recurring IBS 
symptoms.  Writing memos and field notes facilitated reflexivity and enhanced transparency 
and confirmability.  The overarching theme (“being trapped within a vicious cycle”) was 
reminiscent of CBT concepts, prompting a reflexive exploration of whether CBT concepts 
had been imposed by the researchers.  The lead analyst (XX) was a mature male postgraduate 
health psychology student, with no formal CBT training.  Other researchers were trainee and 
experienced health psychologists with and without CBT and clinical experience and an 
academic GP with expertise in IBS.  Before settling on the final themes we deliberately 
reviewed the data and thus confirmed that the ‘vicious cycle’ concept had indeed emerged 
from participants’ accounts. 
Findings 
Interviewees described an everyday life compromised by an illness that, whilst not 
life-threatening or terminal, often had debilitating consequences for professional, personal, 
family and social domains alike.  
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“IBS can be like – a complete disaster in your life. … people don’t associate with it – 
with – a condition that is – like really debilitating and I think – its just like very 
destructive in your life.” (Elijah) 
 
Accounts of treatment seeking for IBS were characterised by a sense of being trapped 
within a “vicious cycle” of alternating hope (for new treatments) and despair (on finding 
them ineffective).  Some interviewees, such as Lucas, discussed how this vicious cycle 
impacted them emotionally.   
 
“I was anxious about being unwell and that caused me anxiety and made unwell, 
which caused me anxiety, so there was a bit of a vicious circle going on and any 
amounts of – of – of – telling me – or telling myself – that this is er something that 
will go away and it wasn’t serious or whatever, um [didn’t] break that cycle.” (Lucas) 
 
While a few interviewees escaped this cycle through increased acceptance of IBS and 
improved self-management, others described a constant battle to control symptoms and a 
seemingly unending quest for a cure.  Typically, participants had tried multiple interventions 
before enrolling in the trial, and appraised pharmaceutical, dietary, and alternative treatments 
in different ways.  Figure 1 depicts the interplay between the themes and subthemes, 
described below with selected illustrative quotes.  In the text below and Figure 1, main 
themes are depicted in bold, sub-themes in italics.   
 
 
Desperation for a cure and hope for positive effects 
On seeking treatment for IBS, participants described desperation for a cure that 
manifested in a willingness to try anything, if there was even the slightest chance it could 
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offer some relief from symptoms.  While they focused mainly on “quick fixes” offered by 
medicines, non-pharmaceutical alternatives were considered.  To identify potential 
treatments, participants drew on recommendations and advice from diverse sources including 
healthcare professionals, friends and family, fellow patients, and the internet.  
 
“Well most of the treatments I've tried have either been through friends of friends of 
friends or have been recommended because someone in a chat room has 
recommended them and – so when you're desperate, you will try – oh I’ll give that a 
go.” (Sophia) 
 
Interviewees then had to manage their hope for positive effects from a new treatment.  
Some resisted the temptation to hope for a cure (particularly when they had extensive 
histories of treatment-seeking), despite hearing success stories from other patients.  Others 
found that success stories and recommendations encouraged them to hope for a cure: 
  
 “I had expectations that it would wave a magic wand overnight” (Grace) 
 
Appraising the effects of diverse treatments 
Having engaged with a treatment, interviewees described appraising it for its 
helpfulness in relieving symptoms and offering physiological and psychological benefits.  
When treatments were appraised as helpful, participants regained a sense of control in their 
quality of life, and could begin breaking the vicious cycle.  Finding a treatment modality that 
relieved symptoms such as bloating in the short-term allowed interviewees to enjoy a social 
life with friends and families and take less time off work.  More commonly, participants were 
disappointed with treatment effects and continued seeking a more effective treatment.  
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Medications 
Medications were the most frequently appraised interventions.  Some participants 
described how medications offered temporary symptom relief (e.g. from bloating and 
stomach cramps) that meant they regained some control and were better able to socialise and 
perform daily activities without worrying that their symptoms would interrupt or embarrass 
them.  Indeed, such worries could be all-encompassing and disabling in themselves so the 
relief from worry was valued as well as the relief from symptoms.   
 
“It’s made my life easier in that respect, that I don’t get caught out in situations where 
I would have been caught out before. So it’s a relief that you can get on and not worry 
about it.” (Jessica) 
 
When over-the-counter medications and prescribed medications were found to be 
unhelpful in that symptom relief was not forthcoming, interviewees often persisted in trying 
different remedies and typically remained open to their potential benefits for others: 
 
“Okay, well – none of them really helped so I didn’t – I didn’t really like any of them. 
Yes – they just – they did not help my – my troublesome symptoms, the bloating and 
the trapped wind at night, so you know, I tried all of them for, whatever, a month or 
some of them I tried for longer and tried – on – you know – separate occasions.” (Alice) 
 
Over half of all participants expressed a general dislike of taking medications for their 
IBS, citing the following reasons: tablets difficult to swallow, inconvenience of having to 
take the medication at very specific times, concerns about falling foul of legal restrictions 
when travelling, childhood upbringing was generally anti-medications, concerns over 
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immediate and longer-term side-effects, feeling that medications treated (or masked) the 
symptoms without addressing underlying causes, and not understanding what they were 
putting into their bodies.   
 
“I don’t like taking drugs because I always wonder what – what side-effects are there 
that perhaps aren’t apparent now, but you then find out, say, 10 or 20 years down the 
line for example.” (Liam) 
 
A general dislike of medications and/or finding them ineffective led many participants 
(42%) to seek other ways of managing IBS (although they didn’t necessarily stop taking 
disliked medications if they provided some relief).  Participants preferred alternatives to 
medication which treat IBS more holistically and avoid the use of chemicals, for example by 
managing their diet or working with a therapist. 
 
“I just didn't like the fact that I would have to take medication for – for something that 
could possibly be controlled in other ways, through perhaps – work with a therapist or 
hypnotherapy or something like that.” (Olivia)  
 
Dietary advice 
Unlike medications, dietary changes were seen to have a social context which shaped 
participants’ appraisals of such interventions.  Participants described experiencing an altered 
relationship with food which could be empowering (when it became a way of controlling 
symptoms) but also demanding.  Trying to identify triggers involved something of a trial and 
error approach, and when trigger foods were identified this was experienced as a double-
edged sword.  On the one hand, it could enhance participants’ sense of control in cases when 
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their symptoms improved.  On the other hand, it could be burdensome and created additional 
anxieties, in that it required considerable forward planning, necessitated detailed attention to 
ingredients when food shopping or eating out, and impacted on participants’ work, social, and 
family lives.  
 
“My work involves a lot of travelling and not really any regular hours. So to get into 
any sort of routine with, say, food, is very tricky and doesn’t leave much option for 
eating anything on the go, so everything has to be cooked in advance, prepared and 
brought with me.”  (Noah) 
 
“I dislike that I have to eat differently to my family; I dislike that it's not readily 
available to buy things while I'm out with others.” (Emily) 
 
Managing symptoms through diet decreased participants’ enjoyment of food. 
Interviewees described finding food boring as they could only eat the same things, they 
disliked feeling unable to eat spontaneously, and they missed previously-enjoyed foods and 
previously-pleasurable aspects of food preparation. 
 
“Also I decided that food is obviously something that’s really nice to enjoy so it’s just 
really sad when you – when you can’t eat like half the foods that you used to eat 
before. So I found that really – like demoralising.” (Elijah) 
 
Furthermore, some participants reported having managed the demands of complex 
dietary changes but without success.   
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“Diet was just very imposing and no positive outcome. So you don't mind, you know, 
doing something that's restricting your life if you're going to get something out of it. I 
got zero out of it so that was frustrating.” (Poppy) 
 
CAM and other treatments 
Twenty-four interviewees (N = 46%) described having sought other options including 
CAM, colonic pack for manual bowel evacuation, and exercise.  While some of these 
approaches were valued for attempting to address root causes of IBS, and not being 
pharmacological, ultimately, they were appraised according to whether they elicited 
meaningful benefits.  As for dietary advice and medications, alternatives that were found 
ineffective were simply seen as another failed attempt that led to frustration and a renewed 
search for other remedies. 
 
“I've tried all sorts, I mean, you know, I've had tablets, I've been to the pain clinic and 
tried mindfulness meditation; I've paid for hypnotherapy, I've paid for acupuncture, 
paid for Chinese medicine, I've been to homoeopaths, I've paid for that. I've tried all 
sorts and nothing – nothing works. I've had CBT in the past and it didn't work then. 
I've tried all sorts.” (James) 
 
 When alternatives such as regular exercise were appraised more positively as 
helping with one’s symptoms, participants also reported experiencing challenges to 
adherence including: lack of time and motivation, feeling lethargic, working long hours, and 
lacking enthusiasm for physical activities that were not inherently enjoyable.   
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“I just found it too – too energetic because my energy levels can be pretty low 
sometimes and I just felt – it wore me out too much, that I didn't really get pleasure in 
it, I suppose that's the word, I didn't find it was pleasurable.” (Amelia) 
 
Disappointment at lack of cure 
Irrespective of their hopes, expectations, or type of intervention, interviewees 
described being disappointed when treatments provided neither a cure nor long-term 
symptom relief.  Interviewees’ desperation to find a cure was fuelled by continuing to 
experience symptom flare-ups with little or no ability to manage them, thus maintaining the 
vicious cycle of treatment seeking.  For example, Isla described being obsessed with keeping 
herself regular because of the pain she experienced, and seeking different medications for 
pain relief. 
 
“I was using a lot of over-the-counter laxatives and some of them very strong, and I 
was just obsessed with taking them, just to try and keep myself regular because I was 
in so much pain. So I would try these ones – which did work but – they would work 
but they would not relieve the pain. So then I tried taking the other ones that were 
more [associated] with relieving the pain and then these actually never worked; I was 
always in pain.” (Isla) 
 
There were additional consequences of having tried ineffective treatments that both 
contributed to and were fuelled by disappointment in treatments.  Feelings of being exploited 
emerged when participants found treatments to be expensive and then ineffective, and were 
perpetuated by the constant email bombardment from companies offering products that 
promised to provide relief from IBS symptoms.   
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“it's costing all the time, you know, you're laying out a lot of money which you might 
not mind if something's really gone well. But to keep laying out money and, in the 
end, you're no different.” (Phoebe) 
 
A lack of confidence in healthcare professionals sometimes emerged when 
participants felt they were being treated as a “case of IBS” rather than a unique individual 
person with IBS, when they felt they were not being treated respectfully, when they felt IBS 
was dismissed as not serious or “all in the mind”, and when they perceived that clinicians had 
taken a trial and error approach (to prescribing medications in particular).  This could also 
decrease participants’ hope for an effective treatment. 
 
 “you suddenly realise – you are an individual and a lot of doctors want to put you in 
one box and treat you for one specific thing – they don't look at you as an individual, 
they look at you as – oh – you take that medication, blah, blah, blah, follow this 
routine and you might be cured.” (Amelia) 
 
“I felt a bit hopeless, to be honest xxx. (I: Yes) I tried quite a few things and I thought 
-   if the doctor can't get it right – what hope have I got.” (Daisy) 
 
Overall, confidence in a healthcare professional’s ability to help cure or find symptom 
relief appeared to wane when participants’ hopes for success were repeatedly met with 
disappointment and at times despair.  It is however important to note that not all participants 
described losing confidence in healthcare professionals, and more positive appraisals of 
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clinicians tended to emerge after effective treatments, helpful referrals, and respectful 
discussions that included providing a rationale for any prescriptions.   
 
“and the doctor prescribed that and she was a brilliant doctor and I think, as well, when 
the doctor has some confidence, you actually kind of believe in the drug a bit more. She 
had her reasons, she explained to me why she was prescribing it, so then I understood 
the point of it, not just chucking another prescription at me and telling me to go away.” 
(Sophia) 
 
On experiencing repeated failed interventions, participants began thinking negatively 
about themselves and the impact IBS had on their quality of life. IBS was seen as a source of 
personal embarrassment because of the perceived stigma around it, and because of 
uncontrollable bodily reactions.  Treatments that offered some relief could also trigger 
negative thoughts, for example about the need to rely on medication to help relieve symptoms 
and the connotations of using antidepressant medications. 
 
“I mean, it’s basically – what’s it called a … tricyclic antidepressant. Now, I’m not 
depressed by any stretch of the imagination, I was just a bit – other than the fact that 
when your IBS [flares up], yes, you get down because – constant trips to the bathroom 
and obviously the way how it makes you feel physically. But other than that – if I 
didn’t have my IBS, I’d be a perfectly happy person.” (Liam)  
 
Developing Acceptance and Coping Strategies 
Some participants had found coping strategies that enabled them to begin to break out 
of the vicious cycle of treatment seeking.  This occurred when participants, such as Jessica, 
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felt they had gained a degree of control over their lives, and/or came to understand IBS as a 
long-term health condition without a permanent “cure”.   
 
“just coming to terms with the fact that it's a condition that’s with people forever and 
er you just have to try and control it as best you can and there will always be er flare-
ups and um days that are not so good and you just have to – you just have to accept 
that.” (Jessica) 
 
When participants accepted that they had a long-term condition for which there 
appeared to be no cure, they seemed better able to resist the temptation to continue seeking 
out new treatments in the hope of a magic cure.  Instead of seeking an instant cure, 
participants took other steps to manage or cope with their symptoms.  These included 
identifying and avoiding food triggers, stopping or adjusting dosages of medications, 
maintaining a routine to reduce feelings of stress, and increasing exercise.   
 
“I've it had a long time anyway, it's not curable; you will try anything but actually the 
bottom line is – it's only one or two small things that really do work – and it's better 
just to stick with them. I see new things come up all the time and I think about them, 
but, you know, I think – well actually – I'm not going to rock the boat and take 
something new because somebody said, oh that's really good – and they make things 
worse.” (Genevieve) 
 
For some interviewees, becoming more aware of their bodies and how their 
symptoms manifest was enough for them to find temporary escape from the vicious cycle that 
had engulfed their lives.  For Poppy, learning more about herself through the “lightning 
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process” (designed to train people to understand mind-body interactions) was an empowering 
process that helped her to cope with her IBS. 
 
“I’m now able to see my triggers. I am now able – to control myself and my emotions 
a lot more, take the stress out of my life. I’ve now got a huge amount of awareness 
about myself and how I react to situations. … So – it’s – empowering me as a person, 
it’s saying use the tools and you can help yourself – which is really empowering.” 
(Poppy) 
  
Finally, the decision by interviewees to enrol into the trial fits in with their desire and 
desperation to find symptom relief on the one hand; and on the other, for those who have 
managed to regain some control in their lives, the ability to help develop further tools and a 
stronger capacity to self-manage, as both Isla and Amelia explain. 
 
“I agreed to do it because, as I said, I was looking for perhaps another tool; I find this 
is another tool to help me through what I was experiencing” (Amelia) 
 
“probably over a year of seeing different doctors and consultants and not finding any 
solution to my – to my problem, so it was basically as like a last remedy thing … I 
was not very optimistic about it” (Isla) 
 
Discussion 
In this study we explored how individuals with refractory IBS seek and go about 
appraising different treatment modalities.  The findings suggest that people primarily appraise 
treatment in terms of its perceived impact on reducing symptom severity but also in terms of 
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how well it fits within and improves (or not) their personal, social, and professional lives. 
However, this must be understood within the broader context of treatment seeking 
behaviours, wherein interviewees described being trapped within a vicious cycle of hope and 
despair for a range of different treatment modalities seen as potential cures.  
A desperation and willingness drove interviewees to try any treatment modality 
available if it offered potential relief.  After a period of time, interviewees appraised the 
treatment modality for its effects on symptoms and quality of life while also taking into 
account, but rarely prioritising, other dimensions including: convenience of the regimen 
itself, whether it sought to address the perceived root causes of IBS, perceived side-effects, 
and cost.  The Common Sense Model posits a bi-directional relationship between beliefs 
about a treatment and appraisals, whether positive (improvement in symptoms) or negative 
(side-effects, or symptoms persist; Diefenbach & Leventhal, 1996).  Therefore, if the 
treatment modality proves beneficial it is predicted that individuals are more likely to 
continue engaging with it, and in turn strengthen their beliefs about the treatment modality as 
useful in relieving symptoms.  In our interviews, people who found the treatment modality 
offered some symptom relief, even if it was only in the short-term, were prepared to continue 
with it, and in some cases, this was described as ‘life-saving’.  Often, but not always, this was 
true even when people found a treatment to be difficult to adhere to or to have unpleasant or 
unwanted side-effects.  For example, whilst diet was seen as a potentially helpful 
intervention, interviewees did not find it necessarily easy to adhere to.  As Casiday, Hungin, 
Cornford, de Wit, and Blell (2009) note, managing strict dietary regimens was time 
consuming and frustrating.  For Horne (2006) this represents a ‘common-sense’ approach to a 
necessity-concerns dilemma, whereby a highly valued outcome outweighs problematic 
aspects of treatment and perceived self-efficacy to maintain a treatment modality becomes 
important.  
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For those trapped within the vicious cycle, disappointment at not being able to find a 
way to reduce symptoms and improve quality of life contributed to negative self-perceptions, 
feelings of being exploited by marketers, and reduced confidence in healthcare professionals. 
Individuals wanted to have faith in healthcare professionals such as GPs and consultants who 
were often perceived as holding a lifeline to curing illnesses; when they were unable to 
provide the answers, interviewees felt helpless and frustrated.  Disappointing experiences 
with healthcare professionals also contributed to negative self-perceptions, when people felt 
their symptoms were not being taken seriously or they were not treated as an individual.  Of 
concern is that the development of negative self-perceptions may further diminish people’s 
ability to cope with flare-ups, by reducing self-efficacy and expectations of response efficacy 
over time. 
Similar reactions have been noted in chronic pain conditions.  A meta-synthesis found 
that patients with chronic low back pain cycled through hope and despair, were left frustrated 
and disappointed when they felt disbelieved by health care professionals and others, and over 
time developed more negative perceptions of self and the future (Froud et al., 2014).  Some 
of these challenges faced by people with chronic pain may result from not easily fitting 
within a traditional biomedical model in which diagnosis leads to curative treatment (Toye et 
al., 2013).  Indeed, patients often expect a prescription aimed to alleviate symptoms or cure 
disease and healthcare professionals are aware of those expectations (Cole, 2014; Teixeira 
Rodrigues, Roques, Figueiras, & Herdeiro, 2013).  Individuals with IBS in the current study 
felt a similar alienation from the biomedical model, in that a cure has not followed on from 
diagnosis and various treatment modalities. 
Within our interviews, the primary route out of the cure-seeking vicious cycle was 
through an acceptance that there is no cure for IBS.  For interviewees in the current study, 
developing acceptance and coping strategies seemed to increase self-efficacy to manage 
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periods of flare-ups and provide a protective barrier against despair when a treatment ceased 
to reduce symptoms.  Similarly, Jakobson Ung et al. (2013)’s interviewees - who had lived 
with IBS for a long time (on average 24 years) - were able to see themselves as ‘healed but 
not cured’ and were able to gain a sense of control in their daily lives.  Acceptance and 
mastery have also been shown to be important in facilitating coping and reducing unhelpful 
cure-seeking in other long-term conditions (see Froud et al., 2014; Garcia-Rueda, Carvajal 
Valcarcel, Saracibar-Razquin, & Arantzamendi Solabarrieta, 2016; Toye et al., 2013).  For 
example, low back pain patients who accepted their condition might not be curable and 
changed their outlook accordingly, were better able to cope with their back pain (Froud et al, 
2014).  
This study has certain methodological strengths and weaknesses.  Strengths include: 
the use of maximum variation sampling to ensure a broad range of people were interviewed; 
the requirement for all interviewees to meet the Rome III criteria (Drossman, 2006) for IBS; 
and the use of established techniques to enhance analytic rigour.  However, it is important to 
bear in mind that interviewees all came from the trial (citation removed for peer review), and 
so all had a history of unsuccessful treatments from primary and/or secondary care.  This 
means that our participants are very likely to have had more unsuccessful or disappointing 
experiences of IBS treatments in the past compared to a community-based sample of people 
with IBS. At the time of interview, our participants had been in the trial for 3 months: this 
might have shaped their reflections on treatment seeking. Further, whilst this paper did not 
explore interviewees’ experiences of CBT, their participation in a CBT trial itself indicates an 
openness to CBT (and potentially other non-medication-based interventions) and ongoing 
treatment seeking.   
The findings suggest some clinical implications.  Clinicians could encourage patients 
to reconceptualise IBS as a condition which they can help to manage themselves with the 
Treatment seeking and appraisal in irritable bowel syndrome 
 
24 
 
right tools.  This change in patients’ perceptions of their IBS has not been a central focus of 
clinical guidelines.  Our findings suggest strengthening the message that IBS is a relapsing 
remitting condition, which can persist but can benefit from active self-management could 
have potential benefit in breaking the ‘vicious cycle’ of desperately seeking treatment and 
repeated disappointment.  Promisingly, Robinson et al. (2006) found educating IBS patients 
with a self-help guidebook significantly reduced perceived symptom severity and reduced 
primary care consultations by 60% compared to controls.  
While symptom reduction appears to be highly valued by many, other outcomes such 
as regaining a sense of control and rediscovering pleasure in food may also be important to 
individuals.  Initiating dialogue about treatment goals may help to foster better patient-
practitioner interactions in IBS consultations.  Such discussions may also enable tailoring of 
proposed management strategies to individuals with IBS, focussing on what is important to 
them, for example being able to live a valued life despite symptoms.  Dialogue about 
treatment-related values could also help patients to feel supported in treatment seeking and 
encourage treatment choices that are based on a more informed appreciation of the various 
costs and benefits of specific medications such as anti-depressants as well as non-
pharmacological interventions.   
In conclusion, this qualitative study has illustrated how individuals with IBS seek and 
appraise treatments in the context of their personal, social, and professional lives, while 
constantly striving for symptom relief.  Treatments are experienced on an emotional 
rollercoaster of hope through to despair, which for some can be time-consuming and 
economically costly.  Supportive discussions about illness perceptions and treatment beliefs 
during clinical encounters with health care professionals could improve patients’ experiences.   
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Table 1 
Summary of the interventions received by each trial arm 
 Therapist-based 
CBT 
Web-based CBT Treatment as usual 
Ongoing 
intervention 
Treatment as usual 
from GP/consultant. 
Treatment as usual from 
GP/consultant. 
Treatment as usual from 
GP/consultant. 
Main 
Intervention 
Therapy based on a 
paper-based 
manual. 
Previously piloted web-
based CBT self-
management programme 
(Regul8; Everitt et al., 
2013). 
 
Intensity Six, 60-minute 
telephone CBT 
sessions over 12 
weeks. 
Eight online modules and 
three, 30-minute therapist 
delivered telephone 
sessions over 12 weeks. 
 
Additional 
sessions 
Two 1-hour booster 
calls at 4- and 8-
months.   
Two 30-minute booster 
calls at 4- and 8-months. 
Upon completion of the 
trial, participants 
offered the trial CBT 
intervention. 
Note: GPs and consultants were given a leaflet summarising the NICE guidelines for IBS 
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Table 2 
Interviewees’ Characteristics (n=52) 
  N % 
Gender Male 12 23.08 
Female 40 76.92 
London Primary Care 10 19.23 
Secondary Care 25 48.07 
Southampton Primary Care 15 28.85 
Secondary Care 2 3.85 
Trial Arm Therapist-based 17 32.69 
Web-based 17 32.69 
Treatment as usual 18 34.62 
Trial Arm (Gender -
Male) 
Therapist-based 4 7.69 
Web-based 3 5.77 
Treatment as usual 5 9.62 
Trial Arm (Gender -
Female) 
Therapist-based 13 25.0 
Web-based 14 26.92 
Treatment as usual 13 25.0 
IBS SSS Remission 4 7.69 
Mild 9 17.31 
Moderate 18 34.62 
Severe 21 40.38 
Ethnicity White British 38 73.08 
White Other 9 17.31 
White Asian 1 1.92 
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Irish 1 1.92 
Indian 1 1.92 
African 1 1.92 
Other 1 1.92 
Note: IBS SSS = IBS Symptom Severity Score 
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Figure 1. Thematic map depicting participants’ experiences of seeking and appraising 
treatments in IBS 
Note: Bold text represents main themes; Italic text indicates sub-themes 
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